Article
The adiposity of CRLM before targeted therapy initiation may serve as a marker to distinguish KRAS mutation status:A retrospective study
2024-03-28
Abstract excerpt
<title>Abstract</title> <p>OBJECTIVE This study aimed to explore the correlation between MRI-related parameters and the Kirsten rat sarcoma viral oncogene (KRAS) gene mutation status in colorectal cancer liver metastases (CRLM) prior to initiating targeted therapy. METHODS This retrospective study enrolled 118 patients diagnosed with colorectal cancer liver metastases, each presenting up to three lesions of the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ecaa7122-eb33-59b4-97d7-6b46511477a0
- DOI
- 10.21203/rs.3.rs-4136576/v1
